KATHERINE HAMMERSCHMIDT: Open Payments
NPI 1922517747 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 21 payments from 8 companies in 2025. Trend: 2023 $275 · 2024 $238 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $193 |
| AstraZeneca Pharmaceuticals LP | 2 | $153 |
| ABBVIE INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| Abbott Laboratories | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $17 |
Products named: MOUNJARO, BREZTRI, QULIPTA, JARDIANCE, AIRSUPRA, FREESTYLE LIBRE 3, Jornay PM, AREXVY.
Industry payments across MO — which companies pay providers there.
